Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A Day Of Reckoning for Aging Facilities: Is It Time To Invest In Change?

This article was originally published in Scrip

Executive Summary

With its acquisition of Hospira, Pfizer joins those struggling to eke out a profit from aging sterile injectables facilities without shutting them down for badly needed upgrades. Meanwhile, flexible, modular next-generation facilities are looming. Bowman Cox, editor of "The Gold Sheet" looks at the possibilities for the industry's golden oldies.

You may also be interested in...

Can We Talk? US FDA Remote Records Review Missteps Worry Industry

Alkermes CRL is just the latest fallout from black-hole process.

US EUA For Lilly’s Bamlanivimab Conditioned On Additional GMP Compliance Requirements

Letter of authorization for COVID-19 therapeutic made at troubled Lilly plant requires independent third-party oversight.

Global Benchmarking Data Offer Path To Improved Drug Manufacturing Quality

Prospective new participants in benchmarking study must share manufacturing plant data by 20 November to see how they measure on quality against industry peers.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts